Investor Backing & Capital Strength:
A $120M funding round announced on June 18, 2024 is highlighted as a strong proxy for expansion capacity. TechCrunch’s year-end recap lists AKASA among U.S. AI startups that raised $100M+ in 2024.
Strategic Partnerships:
Cleveland Clinic rolled out AKASA’s AI coding tools systemwide in early 2025 and expanded to a CDI solution across all U.S. locations by October 13, 2025. An Oracle Cerner collaboration broadens access to AKASA’s automation for EHR customers.
Market Expansion:
AKASA’s site states its client base represents 650+ hospitals and 6,500+ outpatient facilities across all 50 states. Named customer outcomes such as Nebraska Methodist’s reported $2M+ gross revenue lift and the upsell within Cleveland Clinic indicate footprint growth and upsell potential.
